^
Association details:
| Biomarker: | HER-2 overexpression |
|---|---|
| Cancer: | Gastric Cancer |
| Drug: | Zercepac (trastuzumab biosimilar) (HER2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
07/27/2020
Excerpt:
Zercepac should only be used in patients with metastatic gastric cancer (MGC) whose tumours have HER2 overexpression…
